CRR_Call Tracker

Text/HTML

Text/HTML

ValueProductView

ValueProductPastPerformance

Company NameReco DateReco PriceExit PriceExit Date% ReturnIn days
Bharat Forge Ltd. 25/07/20241,593.85952.3007/04/2025 -40.25% 256 days
ITC Ltd. 28/12/2023464.20487.5002/01/2025 5.02% 1 yrs
Britannia Industries Ltd. 27/07/20234,875.805,028.2512/11/2024 3.13% 1 yrs
JSW Steel Ltd. 22/02/2024826.951,003.0026/09/2024 21.29% 217 days
Bajaj Auto Ltd. 22/08/20249,910.0011,930.0017/09/2024 20.38% 26 days
Dr. Reddy's Laboratories Ltd. 26/10/20235,429.306,536.0005/07/2024 20.38% 253 days
Shriram Finance Ltd. 25/04/20242,430.102,955.0028/06/2024 21.60% 64 days
Coal India Ltd. 25/01/2024389.50501.6022/05/2024 28.78% 118 days
Infosys Ltd. 27/10/20221,522.601,411.6019/04/2024 -7.29% 1 yrs
State Bank Of India 25/05/2023581.30782.0505/03/2024 34.53% 285 days

CRR_MVC_PastPerformance

Text/HTML

Our Other Trader Products

EasyDNNNews

142.4 Per Cent Returns From 52-Week Low: Board Likely To Announce Stock Split & Migration From SME to Main Board
DSIJ Intelligence-1

142.4 Per Cent Returns From 52-Week Low: Board Likely To Announce Stock Split & Migration From SME to Main Board

The stock gave multibagger returns of 142.4 per cent from its 52-week low of Rs 982.10 per share.

Jeena Sikho Lifecare Limited informed that a meeting of the Board of Directors of the company is scheduled to be held on Monday, April 21, 2025, inter alia, to consider and approve the following:

  1. Sub-division/ split of existing equity shares having a face value of Rs 10 each and consequential amendment in the Memorandum of Association of the company.
  2. Migration of listed scrip (equity shares) of the company from Emerge (SME) Platform of National Stock Exchange of India Limited (NSE EMERGE) to the Main Board of National Stock Exchange of India Limited (NSE), as well as on the main board of BSE Ltd (BSE).

Jeena Sikho Lifecare has become a significant Ayurvedic healthcare provider in India with a decade of service, offering diverse products and actively engaging in public health through free checkups and yoga sessions to promote wellness. Their extensive network includes 119 clinics and hospitals, including specialized HIIMS and Shuddhi Panchakarma centers, enabling personalized treatments and distribution of over 300 products; a testament to their quality is the NABH accreditation of 17 facilities.

The company plans to establish a new 150-bed hospital in Raigad District, Maharashtra, on leased property in Village Karnala, Taluka Panvel, with operations commencing in July 2025. This strategic expansion, requiring an estimated Rs 6 crore investment from internal funds, aims to broaden their healthcare network and extend quality medical services to a wider population in the region.

The shares of the company have an ROE of 43 per cent and an ROCE of 58 per cent. The stock gave multibagger returns of 142.4 per cent from its 52-week low of Rs 982.10 per share. Investors should keep an eye on this stock.

Disclaimer: The article is for informational purposes only and not investment advice. 

DSIJ’s 'Multibagger Pick’ service recommends well researched multibagger stocks with High Returns potential. If this interests you, do download the service details here.

Previous Article President of India Sold 1,45,63,465 Shares: Debt-Free Defence Shipbuilding Stock Jumps 11 Per Cent; Strong Order Book of Rs 34,787 Crore
Next Article Price Volume breakout stocks: These stocks likely to be in focus tomorrow!
Print
312 Rate this article:
5.0
Please login or register to post comments.

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR